Caron J M, Jones A L, Kirschner M W
J Cell Biol. 1985 Nov;101(5 Pt 1):1763-72. doi: 10.1083/jcb.101.5.1763.
Microtubule polymer levels in mouse 3T6 fibroblasts and primary cultures of rat hepatocytes can be manipulated by treatment of cells with long term, low doses of colcemid. Such treatment produces a rather uniform population of cells with microtubules of reduced lengths. Using this system, we demonstrate (a) that the rate of tubulin synthesis is sensitive to small changes (10%) in microtubule polymer mass and (b) that the percent of inhibition of synthesis is proportional to the level of soluble tubulin. Experiments with hepatocytes indicate that not only synthesis but the stability of tubulin protein was also regulated to maintain a specific level of tubulin. Treatment of hepatocytes with colcemid or other microtubule-depolymerizing drugs reduced the half-life of tubulin from 50 to 2 h, whereas taxol, which stabilizes microtubules, increased the half-life. To assess the consequences of altering microtubule polymer mass, we have analyzed the effect of controlled depolymerization of microtubules in rat hepatocytes on the processing of endocytosed ligands and found it sensitive to small changes in microtubule polymer levels.
通过用长期低剂量的秋水仙酰胺处理细胞,可以调控小鼠3T6成纤维细胞和大鼠肝细胞原代培养物中的微管聚合物水平。这种处理会产生相当均匀的细胞群体,其微管长度缩短。利用这个系统,我们证明:(a)微管蛋白的合成速率对微管聚合物质量的微小变化(10%)敏感;(b)合成的抑制百分比与可溶性微管蛋白水平成正比。对肝细胞的实验表明,不仅微管蛋白的合成,其稳定性也受到调控以维持特定的微管蛋白水平。用秋水仙酰胺或其他微管解聚药物处理肝细胞会使微管蛋白的半衰期从50小时缩短至2小时,而稳定微管的紫杉醇则会延长半衰期。为了评估改变微管聚合物质量的后果,我们分析了大鼠肝细胞中微管的可控解聚对内吞配体加工的影响,发现其对微管聚合物水平的微小变化敏感。